These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21007328)

  • 21. Hormonal management of advanced adenocarcinoma of the prostate.
    Miles BJ
    Henry Ford Hosp Med J; 1989; 37(1):16-8. PubMed ID: 2670839
    [No Abstract]   [Full Text] [Related]  

  • 22. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
    Scherr DS; Pitts WR
    J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies.
    Byar DP; Corle DK
    NCI Monogr; 1988; (7):165-70. PubMed ID: 3050535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of prostate volume by ultrasound in hormonally treated prostate cancer.
    Brandt B; Menu G; el Khansa A; Lardennois B
    Prog Clin Biol Res; 1987; 243B():13-9. PubMed ID: 3309979
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Medical versus surgical androgen suppression therapy for prostate cancer: a 10-year longitudinal cost study.
    Pitts WR
    J Urol; 2001 Aug; 166(2):632. PubMed ID: 11458103
    [No Abstract]   [Full Text] [Related]  

  • 26. Carcinoma of prostate. Increased mortality and cardio-vascular complications associated with oestrogen therapy as compared with orchiectomy.
    Gardner AM; Setakis N
    Bristol Med Chir J; 1983 Jul; 98(367):117-9. PubMed ID: 6616292
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer.
    Pitts WR
    BJU Int; 2004 May; 93(7):1119-20. PubMed ID: 15142186
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Prout GR
    Surg Forum; 1970; 21():540-1. PubMed ID: 5535268
    [No Abstract]   [Full Text] [Related]  

  • 29. The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
    Servadio C
    Prog Clin Biol Res; 1987; 243B():449-53. PubMed ID: 3659039
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Diethylstilbesterol revisited: androgen deprivation, osteoporosis an prostate cancer.
    Pitts WR
    J Urol; 2002 Jul; 168(1):201; author reply 201. PubMed ID: 12050534
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
    Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormonal treatment of carcinoma of the prostate].
    Obata K; Kobayashi H; Murase T; Ohisi M
    Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone therapy in prostate cancer: clinical results].
    Morote-Robles J
    Rev Esp Fisiol; 1990 Mar; 46(1):59-62. PubMed ID: 1697693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoma of the prostate gland; report of a patient treated with orchiectomy and estrogens.
    SHEPP MD; BECK GJ; BAYER I
    Am J Med; 1947 Jan; 2(1):112-20. PubMed ID: 20278456
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy.
    Pollack A; Block NL; Stover BJ; Irvin GL; Fuentes MP; Claflin AJ; Malinin TI
    J Natl Cancer Inst; 1983 May; 70(5):907-14. PubMed ID: 6573535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
    Zincke H
    Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of diethylstilbestrol on the calcium phosphorus and nitrogen metabolism of prostatic carcinoma.
    SCHILLING A; LASZLO D
    J Clin Invest; 1950 Jul; 29(7):918-24. PubMed ID: 15436860
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Olav Erich Yri, Trine Bjoro and Sophie D. Fossa. Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer. Eur Urol 2006;49:54-58.
    Pitts WR
    Eur Urol; 2007 Mar; 51(3):864. PubMed ID: 16860461
    [No Abstract]   [Full Text] [Related]  

  • 39. HYPOCALCEMIA AND HYPOPHOSPHATEMIA ACCOMPANYING OSTEOBLASTIC METASTASES.
    RANDALL RE; LIRENMAN DS
    J Clin Endocrinol Metab; 1964 Dec; 24():1331-3. PubMed ID: 14243178
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recurrence of cancer of the prostate after initial treatment with diethylstilbestrol (DES) in a homogeneous series of 175 cases].
    Reziciner S
    Ann Urol (Paris); 1997; 31(4):213-24. PubMed ID: 9412346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.